Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate biopsy interpretation. Current concepts, 1999.

K A Iczkowski1, D G Bostwick

  • 1Reading Hospital and Medical Center, West Reading, Pennsylvania, USA. iczkowskik@readinghospital.org

The Urologic Clinics of North America
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.

Histopathology·2009
Same author

Exogenous mycoplasmal p37 protein alters gene expression, growth and morphology of prostate cancer cells.

Cytogenetic and genome research·2007
Same author

Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence.

Genes and immunity·2007
Same author

Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex.

Tissue antigens·2007
Same author

Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu.

Journal of clinical pathology·2006
Same author

High grade prostatic intraepithelial neoplasia with squamous differentiation.

Journal of clinical pathology·2006
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Prostate needle biopsy is crucial for diagnosing prostate cancer and predicting patient outcomes. Refined sampling strategies improve diagnostic accuracy when combined with clinical factors for better staging and prognosis.

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Prostate needle biopsy is essential for diagnosing prostate cancer.
  • Accurate diagnosis and outcome prediction are critical for patient management.

Purpose of the Study:

  • To highlight the importance of prostate needle biopsy in cancer diagnosis and outcome prediction.
  • To discuss advancements in prostate sampling techniques.
  • To emphasize the role of pathology findings in conjunction with clinical data.

Main Methods:

  • Review of current literature on prostate biopsy techniques.
  • Analysis of the contribution of pathologic findings to predictive accuracy.
  • Integration of biopsy results with clinical factors.

Related Experiment Videos

Main Results:

  • Prostate needle biopsy plays a key role in prostate cancer diagnosis.
  • Refined prostate sampling strategies enhance diagnostic yield.
  • Pathologic findings from biopsy improve predictive accuracy for cancer stage and individual outcomes.

Conclusions:

  • Prostate needle biopsy remains a cornerstone in prostate cancer management.
  • Ongoing refinements in biopsy techniques are improving diagnostic capabilities.
  • Combining biopsy results with clinical information offers enhanced predictive power for patient outcomes.